임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 1/2상모집 중· Antineutrophil Cytoplasmic Antibody-associated VasculitisCC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
협력: BMS
- 1/2상모집 중· SCHIZOPHRENIA 1 (Disorder)A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
협력: BMS
- 2상모집 중· Central Centrifugal Cicatricial AlopeciaDeucravacitinib in the Treatment of Cicatricial Alopecias
협력: BMS
- 2상모집 중· Phase 2 StudyA Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
협력: BMS
- 단계 미표기모집 중· Ulcerative ColitisA Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
리드: BMS
- 1상모집 중· Diffuse Pleural MesotheliomaA Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
협력: BMS
- 1상모집 중· Colorectal CancerA Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
협력: BMS
- 1/2상모집 중· Advanced Renal Cell Carcinoma (RCC)A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
리드: BMS · 협력: 바이오엔테크
- 단계 미표기모집 중· Non Small Cell Lung Cancer NSCLCA Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)
협력: BMS
- 3상모집 중· Non-small Cell Lung Cancer (NSCLC)A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
리드: BMS · 협력: 바이오엔테크
- 1/2상모집 중· Hepatocellular Carcinoma (HCC)A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
리드: BMS · 협력: 바이오엔테크
- 2/3상모집 중· Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
리드: BMS · 협력: 바이오엔테크
- 3상모집 중· Non-Small Cell Lung Cancer (NSCLC)A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
리드: BMS · 협력: 바이오엔테크
- 단계 미표기모집 중· Lung Non-Small Cell CarcinomaExperiences w/ & Attitudes Towards Immune Chckpt Inhibitors in NSCLC Patients Single Center Survey Based Study
협력: BMS
- 단계 미표기모집 중· Unresectable Hepatocellular CarcinomaFirst-Line Nivolumab Plus Ipilimumab in Unresectable Hepatocellular Carcinoma (J-PROMISE)
리드: BMS
- 1상모집 중· Rheumatoid ArthritisA Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
리드: BMS
- 단계 미표기모집 중· SchizophreniaEffectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
리드: BMS
- 1상모집 중· Healthy VolunteersA Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants
리드: BMS
- 2상모집 중· Cutaneous MelanomaNeo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)
협력: BMS
- 1/2상모집 중· Relapsed/Refractory Small Cell Lung CancerA Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
리드: BMS
- 단계 미표기모집 중· Ulcerative Colitis (UC)Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
리드: BMS
- 단계 미표기모집 중· Obstructive Hypertrophic Cardiomyopathy (oHCM)Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US
리드: BMS
- 1상모집 중· Renal Cell CarcinomaA First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
리드: BMS
- 단계 미표기모집 중· Hypertrophic CardiomyopathyA Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
리드: BMS
- 2상모집 중· Recurrent GlioblastomaA Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
리드: 바이오엔테크 · 협력: BMS
- 해당없음모집 중· Rheumatoid Arthritis (RAHealthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being
협력: BMS
- 2/3상모집 중· Metastatic Non-small Cell Lung Cancer With MTAP DeletionA Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
리드: BMS
- 2/3상모집 중· Untreated, Unresectable, or Metastatic Colorectal CancerA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
리드: BMS · 협력: 바이오엔테크
- 1상모집 중· Healthy VolunteersA Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.
리드: BMS
- 2상모집 중· Pancreatic Ductal Adenocarcinoma (PDAC)A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
리드: 바이오엔테크 · 협력: BMS
- 3상모집 중· Breast NeoplasmsROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
리드: 바이오엔테크 · 협력: BMS
- 1상모집 중· Advanced Solid TumorsA Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors
리드: BMS
- 1/2상모집 중· Solid TumoursA Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
리드: BMS
- 단계 미표기모집 중· Systemic Lupus Erythematosus (SLE)A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
리드: BMS
- 1상모집 중· Healthy VolunteersA Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin
협력: BMS
- 단계 미표기모집 중· SchizophreniaEvaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
리드: BMS
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.